Behçet and LDH/Albumin
- Conditions
- Behcet's DiseaseDisease SeverityAlbuminLactate Dehydrogenase
- Interventions
- Diagnostic Test: LDH/albumin ratio
- Registration Number
- NCT06276829
- Lead Sponsor
- Ataturk University
- Brief Summary
ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls.
Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
Patients with Behçet's disease aged 18-69
- younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Behçet's Disease LDH/albumin ratio - healthy individuals LDH/albumin ratio -
- Primary Outcome Measures
Name Time Method LDH/albumin ratio February 2020 and April 2023
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Erdal Pala
🇹🇷Erzurum, Turkey